Sources and References

Online resources — PubMed Central, Journal of Physiology, American Journal of Physiology: Cell Physiology, Journal of Applied Physiology (pubmed.ncbi.nlm.nih.gov); NIH National Institute on Aging, Biology of Aging Research (nia.nih.gov); MedlinePlus, Muscular Dystrophy and myopathies (medlineplus.gov)

Chapter 1: Skeletal Muscle Structure and Function

Hierarchical Architecture of Skeletal Muscle

Skeletal muscle is among the most complex and functionally versatile tissues in the body, constituting approximately 40% of body mass in a healthy adult and serving indispensable roles in locomotion, respiration, postural stability, thermoregulation, and metabolic homeostasis. Its architecture is hierarchically organised from the molecular scale through fibre, fascicle, and whole muscle levels, and this organisation determines both the mechanical properties of the muscle and the cellular pathways through which it adapts to use, disuse, aging, and disease.

Within each sarcomere, thick filaments — composed of myosin II molecules assembled in a bipolar fashion with their globular heads projecting radially — are interdigitated with thin filaments composed of filamentous actin (F-actin), troponin, and tropomyosin. The myosin head contains both an actin-binding domain and an ATPase domain, and the cyclical attachment, force generation, and detachment of myosin heads from actin — driven by ATP hydrolysis — constitutes the fundamental mechanochemical event of muscle contraction. The sliding filament theory, developed independently by Hugh Huxley and Andrew Huxley in 1954, describes how the force generated by myosin cross-bridges sliding actin filaments toward the centre of the sarcomere produces sarcomere shortening without changes in filament length — a model validated by decades of X-ray diffraction, electron microscopy, and single-molecule biophysical studies.

Fibre Type Diversity and Metabolic Specialisation

Skeletal muscle is not a homogeneous tissue. It is composed of fibres that differ in their myosin heavy chain (MyHC) isoform composition, metabolic enzyme profile, mitochondrial content, calcium-handling characteristics, and consequently in their contractile speed, force production, and fatigue resistance. The classical classification recognises three major fibre types in human skeletal muscle:

Type I fibres (slow-twitch, oxidative) express the slow MyHC isoform (MyHC-I or MyHC-beta), have a high mitochondrial density and oxidative enzyme activity (citrate synthase, succinate dehydrogenase), a rich capillary supply, high myoglobin content (giving them a red appearance), slow cross-bridge cycling kinetics, and high resistance to fatigue. They are recruited preferentially during low-intensity, sustained activities and contribute the majority of force during everyday postural and ambulatory tasks.

Type IIa fibres (fast-twitch, oxidative-glycolytic) express the fast MyHC-IIa isoform, have intermediate mitochondrial content and oxidative capacity, fast cross-bridge cycling, and intermediate fatigue resistance. They are recruited at intermediate exercise intensities and represent a metabolically versatile “hybrid” fibre type.

Type IIx fibres (fast-twitch, glycolytic; formerly misidentified as Type IIb in humans) express MyHC-IIx, have low mitochondrial density and high glycolytic enzyme activity, the fastest cross-bridge cycling kinetics among human fibre types, the highest peak force and power output, and the most rapid fatigue. They are recruited only during high-intensity efforts.

Fibre type composition in any given muscle is not fixed at birth but is dynamically regulated by neuromuscular activity patterns, mechanical loading, hormonal signals, and innervation. The seminal cross-innervation experiments of John Eccles demonstrated that fibre type identity is largely determined by the motor neuron’s firing pattern — slow motor neurons drive type I phenotypes; fast motor neurons drive type II phenotypes — through activity-dependent regulation of gene expression by the calcineurin-NFAT pathway and other activity-sensitive transcription factors.

Chapter 2: Skeletal Muscle Development and Aging

Myogenesis: From Stem Cell to Functional Muscle

The formation of skeletal muscle during embryonic development — primary myogenesis — proceeds from the dermomyotome of the somites, from which committed skeletal muscle progenitors (myoblasts) delaminate, migrate to their target locations, and fuse with one another to form primary myotubes. These primary myotubes are further enveloped by secondary myoblasts to form secondary and tertiary myotubes, and the whole process is orchestrated by a combinatorial code of myogenic regulatory factors (MRFs): MyoD, Myf5, MRF4, and myogenin — basic helix-loop-helix transcription factors that are hierarchically required for myoblast determination (MyoD and Myf5) and terminal differentiation (myogenin and MRF4). Knockout of both MyoD and Myf5 produces mice with completely absent skeletal muscle, demonstrating the non-redundant but mutually compensating roles of these factors in specifying the myogenic lineage.

Postnatal muscle growth occurs primarily through hypertrophy — enlargement of existing fibres — rather than through the formation of new fibres. This hypertrophy requires the addition of new myonuclei to maintain the myonuclear domain — the cytoplasmic volume served by each nucleus — within a physiologically sustainable range, and this nuclear accretion is accomplished by the activation, proliferation, and fusion of satellite cells — the resident stem cell population of adult skeletal muscle.

Sarcopenia: The Aging of Skeletal Muscle

Sarcopenia is the progressive, generalised loss of skeletal muscle mass, strength, and physical performance that characterises normal human aging. Muscle mass begins to decline from approximately the fourth decade of life, at a rate of approximately 0.5–1% per year. After the sixth decade, the rate of decline accelerates to 1–2% per year, and an average 75-year-old may have lost 25–30% of the peak muscle mass they possessed as a young adult. Associated with this loss of mass is an even greater loss of strength and power — the loss of power occurs at a rate approximately double that of mass — because the fibres that are preferentially lost or atrophied in sarcopenia are the fast, Type IIx fibres that generate the highest force and power per cross-sectional area.

The mechanisms of sarcopenia are multiple, interacting, and not fully elucidated. Among the most robustly established contributors:

Denervation and reinnervation imbalance — the progressive loss of alpha motor neurons from the ventral horn of the spinal cord with aging, which is greatest for the large, fast-conducting motor neurons innervating Type II fibres. The surviving motor neurons partially compensate by reinnervating orphaned fibres from lost motor units (collateral reinnervation), but this process is incomplete and creates large, physiologically heterogeneous motor units in which fast fibres may be driven by slow axons or vice versa. The consequence is a shift toward a slower, lower-force fibre type composition and reduced motor unit discharge rates.

Anabolic resistance — the impaired ability of aged muscle to mount a full protein synthetic response to anabolic stimuli including dietary protein, particularly the essential amino acid leucine, and mechanical loading. Aged muscle requires higher doses of protein (approximately 0.4 g/kg per meal vs 0.25 g/kg in young adults) to achieve maximal stimulation of muscle protein synthesis (MPS), and even maximal MPS rates may be lower in absolute terms than in young muscle. The molecular basis of anabolic resistance involves reduced sensitivity of mTORC1 signalling to leucine and insulin, impaired amino acid sensing by the Rag GTPases that recruit mTORC1 to the lysosomal surface, and downstream translational inefficiencies.

Chronic low-grade inflammation (inflammaging) — the elevation of circulating pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta, CRP) characteristic of healthy aging, even in the absence of overt inflammatory disease. These cytokines promote muscle protein degradation through the ubiquitin-proteasome system and autophagy-lysosome pathway, simultaneously suppressing protein synthesis through inhibition of IRS-1/Akt/mTORC1 signalling.

Chapter 3: Skeletal Muscle Adaptations to Disease

Muscular Dystrophies

The muscular dystrophies are a genetically heterogeneous group of inherited disorders characterised by progressive muscle wasting and weakness, arising from mutations in genes encoding structural proteins of the dystrophin-associated protein complex (DAPC) or other components essential to sarcolemmal integrity or nuclear function.

Duchenne muscular dystrophy (DMD) is the most common and severe childhood muscular dystrophy, caused by loss-of-function mutations in the X-linked DMD gene encoding dystrophin — a 427 kDa rod-shaped protein that anchors the cytoskeletal actin network to the extracellular matrix via the DAPC at the inner surface of the sarcolemma. In the absence of dystrophin, the sarcolemma is mechanically fragile and is damaged by the shear forces of eccentric muscle contraction, allowing calcium influx and activating a cascade of calcium-dependent proteases (calpains), mitochondrial dysfunction, and ultimately necrosis. The resulting cycles of necrosis and regeneration — initially compensated by satellite cell-mediated muscle repair — ultimately exhaust the regenerative capacity of the satellite cell pool, leading to fibrotic replacement of muscle tissue and progressive contracture.

Heart Failure and COPD: Skeletal Muscle as a Systemic Target

Chronic systemic diseases whose primary pathology lies outside the skeletal muscle — notably chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) — nevertheless produce profound skeletal muscle dysfunction that is a major determinant of exercise intolerance, functional capacity, quality of life, and mortality in these populations. The mechanisms of muscle dysfunction in these conditions share common elements: physical inactivity, nutritional deficits, elevated circulating inflammatory cytokines, hormonal changes (reduced testosterone, IGF-1, elevated cortisol), oxidative stress, and — particularly in COPD — systemic hypoxia.

In CHF, reduced cardiac output limits oxygen delivery to exercising muscle, and the chronic neurohormonal activation (elevated angiotensin II, catecholamines) creates a systemic catabolic environment. Skeletal muscle in CHF exhibits fibre type shifts toward slower, less oxidative fibres, reduced mitochondrial enzyme activity, increased fatigability at submaximal workloads, and impaired calcium cycling. These changes impair peripheral oxygen extraction efficiency and increase ventilatory demand for a given workload, contributing to the exertional dyspnoea that is a hallmark symptom of advanced heart failure.

Chapter 4: Skeletal Muscle Regeneration and Satellite Cells

Satellite Cell Biology

Satellite cells — first identified by Alexander Mauro using electron microscopy in 1961 — are tissue-resident stem cells located beneath the basal lamina of skeletal muscle fibres but outside the sarcolemma, in a precise anatomical “satellite” position. Under normal conditions the vast majority of satellite cells are mitotically quiescent, arrested in the G0 phase of the cell cycle. This quiescence is actively maintained by niche signals including Notch ligands presented by the subjacent myofibre membrane, Wnt inhibitors in the extracellular matrix, and the stiffness of the satellite cell’s mechanical microenvironment, which is matched to the pericellular collagen composition of the basal lamina.

The activation of satellite cells following muscle injury is triggered by the release of growth factors from the damaged myofibre, activated macrophages, and the extracellular matrix: hepatocyte growth factor (HGF), fibroblast growth factor (FGF), insulin-like growth factor 1 (IGF-1), and nitric oxide, among others. Activated satellite cells upregulate MyoD, re-enter the cell cycle, and proliferate rapidly. A proportion of daughter cells undergo terminal differentiation — expressing myogenin and fusing with the damaged fibre or with one another — while another proportion returns to quiescence after self-renewal, replenishing the satellite cell pool for future regenerative challenges.

Satellite Cells in Aging

One of the most consequential changes in aged muscle is the decline in satellite cell number, activation efficiency, and regenerative capacity — changes that underlie the reduced regenerative competence of aged muscle following injury or atrophy. The satellite cell pool diminishes by approximately 50% between young adulthood and old age in human skeletal muscle, with the greatest losses in Type II fibre-associated satellite cells. The remaining satellite cells exhibit intrinsic aging changes — elevated p16INK4a expression driving cell cycle arrest (senescence), impaired Notch signalling limiting proliferative response, epigenetic changes reducing chromatin accessibility at MyoD and myogenin promoters, and elevated canonical Wnt signalling that promotes fibrogenic rather than myogenic differentiation.

Landmark experiments by Conboy, Rando, and colleagues using heterochronic parabiosis — surgically joining the circulatory systems of young and old mice — demonstrated that aged satellite cells retain substantial regenerative capacity when exposed to a young systemic environment, implicating circulating factors rather than irreversible intrinsic changes as the primary determinants of impaired regeneration in aged muscle. The identity of the circulating factors that inhibit regeneration in aging (including GDF11, CCL11, and TGF-beta) and those that promote it (including GDF5, beta2 microglobulin) has been intensely investigated, with important implications for therapeutic restoration of regenerative capacity.

Chapter 5: Mitochondria — Structure, Function, and Dysfunction in Skeletal Muscle

Mitochondrial Architecture and Energetics

Mitochondria occupy a central position in the physiology of skeletal muscle, not only as the primary site of ATP synthesis through oxidative phosphorylation but as regulators of cellular calcium homeostasis, reactive oxygen species production, apoptotic signalling, and the integration of nutrient-sensing and energy-sensing pathways. In skeletal muscle, mitochondria form a dynamic, interconnected network — organised as subsarcolemmal mitochondria beneath the plasma membrane and intermyofibrillar mitochondria nestled between the contractile filaments, positioned to minimise diffusion distances for the ATP they produce and the oxygen they consume.

The inner mitochondrial membrane harbours the five protein complexes of the electron transport chain (ETC) and ATP synthase:

Complex I (NADH dehydrogenase) accepts electrons from NADH generated by the TCA cycle (among other sources) and transfers them to ubiquinone (coenzyme Q), pumping 4 protons from the matrix to the intermembrane space per electron pair.

Complex II (succinate dehydrogenase) accepts electrons from FADH₂ and transfers them to ubiquinone without proton pumping — hence FADH₂ generates less ATP per molecule than NADH.

Complex III (cytochrome bc1 complex) accepts electrons from reduced ubiquinol and transfers them to cytochrome c, pumping 4 protons per electron pair.

Complex IV (cytochrome c oxidase) accepts electrons from reduced cytochrome c and transfers them to molecular oxygen, reducing it to water — the terminal reaction of the ETC. 4 protons are pumped per electron pair.

Complex V (ATP synthase / F₁F₀-ATPase) harnesses the proton gradient — the protonmotive force — established by Complexes I, III, and IV to drive the synthesis of ATP from ADP and inorganic phosphate, rotating the gamma subunit of the F₁ head like a molecular motor.

Mitochondrial Dysfunction in Aging and Disease

Mitochondrial function declines progressively with aging in skeletal muscle, contributing substantially to the reduction in oxidative phosphorylation capacity, the reduction in maximal oxygen uptake (VO₂max), and the increase in intracellular ROS production that characterise aged muscle. The mechanisms of age-related mitochondrial dysfunction are multiple and interrelated.

Mitochondrial dynamics — the regulated balance between mitochondrial fusion and fission — is critical for maintaining a healthy mitochondrial network. Fusion (mediated by MFN1, MFN2, and OPA1) allows complementation between damaged and healthy mitochondrial components, diluting mtDNA mutations and enabling metabolic cooperation. Fission (mediated by DRP1, FIS1) segregates damaged mitochondrial components for selective elimination by mitophagy — the autophagy-mediated degradation of damaged mitochondria via the PINK1-Parkin pathway. In aged muscle, the balance of mitochondrial dynamics shifts toward fission and reduced mitophagy, leading to accumulation of dysfunctional mitochondria that amplify ROS production and pro-apoptotic signalling.

Chapter 6: Free Radicals and Oxidative Stress in Skeletal Muscle

Reactive Oxygen Species: Sources and Chemistry

Reactive oxygen species (ROS) are highly reactive molecular species derived from the partial reduction of molecular oxygen. The principal ROS of biological relevance include the superoxide anion radical (O₂•⁻), hydrogen peroxide (H₂O₂), and the hydroxyl radical (•OH). Within skeletal muscle, the major sources of ROS are the mitochondrial electron transport chain (particularly Complexes I and III), NADPH oxidase (NOX) isoforms at the sarcolemma and sarcoplasmic reticulum, and xanthine oxidase. At physiological concentrations, ROS serve as essential redox signalling molecules — activating transcription factors such as NF-κB and Nrf2, modulating kinase activities, and regulating gene expression programs involved in adaptation to exercise, inflammation resolution, and mitochondrial biogenesis.

The antioxidant defence system of skeletal muscle includes enzymatic and non-enzymatic components. Superoxide dismutase (SOD) — present in two isoforms: CuZn-SOD in the cytosol (SOD1) and Mn-SOD in the mitochondrial matrix (SOD2) — catalyses the dismutation of O₂•⁻ to H₂O₂. Catalase and the glutathione peroxidase (GPx) family reduce H₂O₂ to water, with GPx using reduced glutathione (GSH) as the electron donor. Thioredoxin and peroxiredoxin systems provide additional peroxide reduction capacity. The transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) is the master regulator of antioxidant gene expression; upon activation by oxidative and electrophilic stress it translocates from the cytosol to the nucleus and drives expression of antioxidant enzymes (HO-1, NQO1, catalase, GPx) through antioxidant response element (ARE) sequences in their promoters.

Oxidative Stress in Muscle Aging and Disease

In aged muscle, the balance between ROS production and antioxidant defence shifts toward net oxidative stress, reflecting both increased mitochondrial ROS generation from dysfunctional ETC complexes and age-related reductions in antioxidant enzyme activity. The resulting oxidative modifications of myofibrillar proteins — particularly actin and myosin — impair their function, reducing cross-bridge cycling kinetics and maximum force production independent of any loss of protein quantity. Carbonylation of myosin heavy chain correlates with reduced single-fibre maximum velocity of shortening in aged human muscle.

In dystrophic muscle (DMD), the chronic sarcolemmal fragility creates repeated cycles of focal necrosis, calcium influx, and inflammatory cell infiltration — each episode generating a local oxidative burst that damages surrounding tissue. The elevated ROS in dystrophic muscle further activate NF-κB, sustaining the pro-inflammatory gene expression programme that recruits additional inflammatory cells and perpetuates the destructive cycle.

Chapter 7: Apoptosis and Cell Death in Skeletal Muscle

Mechanisms of Apoptosis

Apoptosis is a form of programmed cell death characterised by defined morphological features — cell shrinkage, chromatin condensation and fragmentation, nuclear blebbing, and formation of membrane-bounded apoptotic bodies — and by the biochemical hallmark of internucleosomal DNA laddering, resulting from the activation of caspase-activated DNase (CAD). In contrast to necrosis — passive, uncontrolled cell death caused by overwhelmingly injurious stimuli, characterised by cell swelling, membrane rupture, and the release of cellular contents that provoke inflammation — apoptosis is an active, energy-requiring process that allows cell elimination without inflammation.

In skeletal muscle, the multinucleated architecture creates a unique relationship between apoptosis and fibre viability. A single myofibre contains hundreds of myonuclei distributed along its length; the loss of a subset of nuclei through apoptosis may not kill the fibre outright (in contrast to mononucleated cells where nuclear loss is invariably lethal) but rather reduces the myonuclear domain and the fibre’s transcriptional capacity, contributing to atrophy. The term myonuclear apoptosis distinguishes this phenomenon — selective elimination of nuclei within a living fibre — from fibre death, though the distinction is not always maintained clearly in the literature.

Apoptosis in Muscle Aging and Disease

Age-related increases in myonuclear apoptosis are well-documented in both rodent and human skeletal muscle. Markers of both intrinsic pathway activation (elevated BAX:BCL-2 ratio, cytochrome c release, caspase-9 and -3 activation) and extrinsic pathway activation (elevated FasL, FADD, and caspase-8 activity) are elevated in aged muscle and correlate inversely with fibre cross-sectional area and muscle mass. Mitochondrial dysfunction contributes to apoptotic activation in aged muscle through multiple mechanisms: impaired membrane potential reduces Bcl-2-mediated outer membrane protection; elevated ROS oxidise cardiolipin, causing cytochrome c to dissociate from the inner membrane and become available for release; and mPTP opening — facilitated by elevated mitochondrial calcium and ROS — directly releases apoptogenic factors into the cytosol.

Physical activity powerfully attenuates apoptotic activation in aged muscle. Exercise reduces the BAX:BCL-2 ratio, decreases cytochrome c release, and reduces caspase-3 activation through mechanisms including enhanced antioxidant capacity, increased heat shock protein (HSP) expression (HSP70 and HSP27 bind cytochrome c and AIF, preventing their interaction with apoptosomal components), and activation of the PI3K/Akt survival signalling pathway. The pro-survival effects of exercise on aged muscle apoptosis are a compelling mechanistic rationale for exercise prescription as a therapeutic intervention in sarcopenia.

Chapter 8: Cell Degradation and Autophagy in Skeletal Muscle

The Ubiquitin-Proteasome System

Protein degradation in skeletal muscle is mediated primarily by two systems: the ubiquitin-proteasome system (UPS) and the autophagy-lysosome pathway (ALP). The UPS is responsible for the selective degradation of individual, short-lived, or damaged proteins, while the ALP degrades larger cargoes including organelles, protein aggregates, and cytosolic contents in bulk.

The ubiquitin-proteasome system operates through a three-enzyme cascade. E1 (ubiquitin-activating enzymes) form a high-energy thioester bond between ubiquitin and a cysteine residue in the active site, activating ubiquitin in an ATP-dependent reaction. E2 (ubiquitin-conjugating enzymes) transfer ubiquitin from E1 to their own cysteine. E3 (ubiquitin ligases) confer substrate specificity, recognising specific protein substrates and catalysing the transfer of ubiquitin from E2 to a lysine residue on the target protein. Successive ubiquitination events build a polyubiquitin chain (linked through K48 of ubiquitin) that serves as the proteasomal degradation signal. The substrate is delivered to and unfolded by the 19S regulatory cap of the 26S proteasome, then threaded into the 20S catalytic core barrel where it is cleaved by chymotrypsin-like, trypsin-like, and caspase-like protease activities.

In skeletal muscle, the most important E3 ligases mediating atrophic signalling are MAFbx (muscle atrophy F-box, also called atrogin-1) and MuRF1 (muscle RING finger protein 1). Both are dramatically upregulated — by 8-fold and 4-fold respectively — in mouse skeletal muscle within 24–48 hours of denervation, immobilisation, or glucocorticoid treatment, and their expression levels correlate with the rate of atrophy. MAFbx targets MyoD, eukaryotic initiation factor 3f (eIF3f), and other translational regulators for degradation, reducing protein synthesis capacity. MuRF1 ubiquitinates myofibrillar proteins — myosin heavy chain, myosin binding protein C, troponins — targeting the contractile apparatus for proteasomal degradation. Both genes are under the transcriptional control of the FOXO family of transcription factors, whose nuclear localisation is regulated by Akt: when Akt activity is high (as in the presence of IGF-1 or insulin signalling), FOXO is phosphorylated and retained in the cytosol, MAFbx and MuRF1 expression is suppressed, and the muscle is in an anabolic state.

Autophagy in Skeletal Muscle

Macroautophagy (hereafter autophagy) is a conserved cellular degradation pathway in which cytoplasmic contents — organelles, protein aggregates, lipid droplets, intracellular pathogens — are sequestered within double-membrane vesicles called autophagosomes, which then fuse with lysosomes to form autolysosomes in which the cargo is degraded by acidic lysosomal hydrolases and the resulting building blocks (amino acids, fatty acids, nucleotides) are recycled to the cytosol.

Autophagy in skeletal muscle plays a fundamentally important quality-control role, and its dysregulation in either direction — insufficient autophagy or excessive autophagy — has pathological consequences. Autophagy insufficiency leads to the accumulation of dysfunctional mitochondria, damaged proteins, and toxic protein aggregates within muscle fibres. Muscle-specific knockout of key autophagy genes (Atg5, Atg7) in mice produces a myopathy characterised by accumulation of aberrant mitochondria, ER stress, and progressive muscle wasting. Excessive autophagy can contribute to muscle atrophy by degrading contractile proteins and organelles at rates that exceed synthetic capacity, as observed in cachexia, denervation atrophy, and — to a lesser extent — normal aging.

Chapter 9: Inflammation in Skeletal Muscle

Inflammatory Responses to Muscle Injury

The inflammatory response to skeletal muscle injury is essential for effective repair and regeneration. An inflammatory response that is too weak fails to clear necrotic debris and coordinate satellite cell activation; one that is too strong or too prolonged impairs regeneration, promotes fibrosis, and perpetuates damage. The inflammatory cascade in injured muscle follows a stereotyped temporal sequence coordinated by intercellular communication among damaged myofibres, endothelial cells, circulating leukocytes, and tissue macrophages.

Within the first hours of injury, neutrophils arrive first, attracted by chemokines (CXCL1, CXCL5, CXCL8) released by damaged cells and activated endothelium. Neutrophils release ROS, proteases, and cytokines that amplify the inflammatory signal and help phagocytose cellular debris. This acute neutrophilic phase transitions within 24–48 hours to a pro-inflammatory macrophage (M1-like) phase, in which classical monocyte-derived macrophages expressing iNOS, TNF-alpha, IL-1beta, and IL-6 phagocytose necrotic debris through complement- and antibody-dependent mechanisms.

The critical transition from inflammation to regeneration is accomplished by the phenotypic shift of M1-like macrophages to an anti-inflammatory, pro-regenerative M2-like phenotype, expressing IL-4R, arginase-1, IL-10, and TGF-beta. M2-like macrophages support satellite cell proliferation and differentiation through the secretion of growth factors (IGF-1, HGF) and through direct cell-contact interactions, and they promote matrix remodelling through the modulation of metalloproteinase activity and TGF-beta signalling to fibro-adipogenic progenitors. The failure of this macrophage phenotypic switch — observed in aged muscle, in dystrophic muscle, and in chronic inflammatory conditions — is associated with incomplete regeneration and fibrosis.

Inflammaging and Skeletal Muscle

Inflammaging — the chronic, low-grade, sterile inflammatory state that characterises normal aging — is a critical driver of sarcopenia. Circulating concentrations of IL-6, TNF-alpha, IL-1beta, and C-reactive protein (CRP) are elevated two-to-fourfold in healthy older adults compared to young adults, and these elevations predict the rate of muscle mass loss, strength decline, and functional impairment longitudinally. The sources of circulating inflammatory mediators in aging include visceral adipose tissue (adipokines from adipocytes and adipose macrophages), the senescent cell burden (SASP — the senescence-associated secretory phenotype), gut dysbiosis (translocation of bacterial LPS across an aging intestinal epithelium), and the myofibre mitochondria themselves (cytokines and mitokines secreted in response to mitochondrial stress).

Exercise as anti-inflammatory intervention — the evidence is robust and mechanistically diverse. Acute exercise generates an acute, transient inflammatory response — a surge of IL-6 from contracting muscle (muscle-derived IL-6, or myokine IL-6, lacks the NF-κB-dependent pro-inflammatory associations of macrophage-derived IL-6 and instead acts as an energy-sensing signal and promotes an anti-inflammatory cytokine profile through induction of IL-10 and IL-1 receptor antagonist). Repeated bouts of exercise, through the cumulative anti-inflammatory effects of this response, reduce resting circulating concentrations of TNF-alpha, IL-6, and CRP in older adults, attenuate macrophage infiltration into aged muscle, and reduce the SASP of senescent cells — a cluster of mechanisms that collectively slow the inflammaging-driven acceleration of sarcopenia.

Influence of Physical Activity on Muscle Aging and Disease

The capacity of physical activity to modify virtually every pathophysiological mechanism discussed in this course — ROS accumulation, apoptotic activation, autophagy dysregulation, inflammaging, anabolic resistance, satellite cell activation, mitochondrial dysfunction — makes it the most broadly effective and evidence-based therapeutic intervention available for skeletal muscle aging and disease.

Resistance training is the gold standard intervention for attenuating sarcopenia, producing increases in muscle fibre cross-sectional area, muscle strength, and physical performance even in the very old (including adults over 90). Its mechanisms include acute stimulation of muscle protein synthesis via mechanical activation of mTORC1 (through the integrin-focal adhesion kinase-PI3K axis, and through local IGF-1 production), satellite cell activation and myonuclear accretion, and the anti-apoptotic and pro-autophagic adaptations described above.

Endurance training powerfully stimulates mitochondrial biogenesis — the synthesis of new mitochondria and expansion of the mitochondrial network — primarily through activation of PGC-1alpha (peroxisome proliferator-activated receptor gamma coactivator-1 alpha), the master transcriptional coactivator of mitochondrial biogenesis. PGC-1alpha is activated by multiple exercise-sensitive signals including AMPK (which senses the decrease in cellular energy charge during exercise) and CaMKII (which senses elevated cytosolic calcium during contraction). Active PGC-1alpha coactivates NRF1 and NRF2 (nuclear respiratory factors), which drive expression of nuclear-encoded mitochondrial genes, while also promoting expression of TFAM (mitochondrial transcription factor A), which translocates to mitochondria to drive replication and transcription of mtDNA. The result is a net increase in mitochondrial content, electron transport chain capacity, and oxidative phosphorylation efficiency.